Ajanta Pharma has informed that a meeting of the Board of Directors of the Company will be held on February 1, 2016, to consider and approve Unaudited Financial Results of the Company for the third quarter and nine months ended December 31, 2015(Q3).
The above information is a part of company’s filings submitted to BSE.